An intricate relationship between pain and depression: clinical correlates, coactivation factors and therapeutic targets

Explore this paper's citation graph

Summary

The neurobiological substrates and neuroanatomical pathways involved in pain–depression dyad along with newer therapeutic targets and the introduction of triple reuptake inhibitors, agomelatine, vilazodone and ketamine with novel mechanism of action appear to be of promising potential for pain with depression.

Type
article
Published
2014-01-13
Cited by
76
References
245

Keywords

Attendance, Ethnic group, General partnership, Medical education, Significant difference

References

Cited by

Related papers